Publications
- Cellular and humoral immune response to SARS-CoV-2 mRNA vaccines in patients treated with either Ibrutinib or Rituximab2023 | Third Faculty of Medicine
- Brentuximab vedotin consolidation therapy after autologous stem cell transplantation in relapsed/refractory classic Hodgkin lymphoma patients in the Czech Republic2023 | Third Faculty of Medicine, First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Cognitive impairment associated with Hodgkin's lymphoma and chemotherapy2023 | Third Faculty of Medicine, First Faculty of Medicine
- Fever of unknown origin2021 | Central Library of Charles University, Third Faculty of Medicine, Second Faculty of Medicine
- Fever of unknown origin: case reports from routine clinical practice and a review2021 | Third Faculty of Medicine, Second Faculty of Medicine
- Outcome of elderly patients with classical Hodgkin's lymphoma2020 | Third Faculty of Medicine, First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Chemotherapy-related cognitive impairment in patients with hodgkin lymphoma-pathophysiology and risk factors2017 | Central Library of Charles University, Third Faculty of Medicine
- Clinical case: idelalisib-induced immunoglobulin flare2017 | Central Library of Charles University, Third Faculty of Medicine
- Rituximab - induced coagulopathy2012 | Central Library of Charles University, Third Faculty of Medicine
Loading network view...